The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. European Medical Solutions's current ratio for the quarter that ended in Dec. 2025 was 1.43.
European Medical Solutions has a current ratio of 1.43. It generally indicates good short-term financial strength.
The historical rank and industry rank for European Medical Solutions's Current Ratio or its related term are showing as below:
STU:AS00'
s Current Ratio Range Over the Past 10 Years
Min: 0.3 Med: 1.56 Max: 6.87
Current: 1.43
During the past 13 years, European Medical Solutions's highest Current Ratio was 6.87. The lowest was 0.30. And the median was 1.56.
STU:AS00's Current Ratio is ranked worse than 77.2% of 1412
companies
in the Biotechnology industry
Industry Median: 3.89
vs STU:AS00: 1.43
European Medical Solutions (STU:AS00) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
European Medical Solutions Current Ratio Related Terms
European Medical Solutions Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:AS00 vs VRTX, REGN, ALNY: Current Ratio Comparison
For the Biotechnology subindustry, European Medical Solutions's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's Current Ratio distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
European Medical Solutions (STU:AS00) has a Current Ratio of 1.43 as of Dec. 2025. This is near median its historical median of 1.56. Over the past decade, European Medical Solutions' Current Ratio has ranged from 0.30 to 6.87. According to the industry distribution chart, European Medical Solutions ranks #1090 out of 1412 companies in the Biotechnology industry, placing it in the top 77.2%.
Is European Medical Solutions' Current Ratio too high?
European Medical Solutions' current Current Ratio of 1.43 is near median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 6.87. The Biotechnology industry median Current Ratio is 3.89. European Medical Solutions' value of 1.43 is 63.2% below this industry median. Based on the distribution chart, European Medical Solutions ranks #1090 out of 1412 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, European Medical Solutions has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' Current Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #1090 out of 1412 companies for Current Ratio. This places European Medical Solutions in the lower half of its industry. The industry median Current Ratio is 3.89. European Medical Solutions' value of 1.43 is 63.2% below this benchmark. Historically, European Medical Solutions' own Current Ratio has ranged from 0.30 to 6.87 over the past decade. While the company's 10-year median is 1.56 vs. the industry median of 3.89, European Medical Solutions has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. European Medical Solutions's current Current Ratio of 1.43 is 63.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. European Medical Solutions's current Current Ratio is 1.43, which is near median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current Current Ratio of 1.43. The stock's GF Value™ is €8.11, compared to a current price of €4.72 — trading 41.8% below its estimated fair value. The current Current Ratio is 1.43, which is near median its 10-year median of 1.56 and 63.2% below the Biotechnology industry median of 3.89. European Medical Solutions' overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current Current Ratio is 1.43 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is European Medical Solutions (STU:AS00) Overvalued in 2026?
Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued.
The current stock price of €4.72 is trading 41.8% below its estimated GF Value™ of €8.11.
Key valuation signals for STU:AS00:
Current Ratio: 1.43 (near median its 10-year median of 1.56)
GF Value™: €8.11 vs. price of €4.72 (41.8% below fair value)
Industry Position: 63.2% below the Biotechnology median (#1090 of 1412)
No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
47GF Score
Get the complete analysis for STU:AS00
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AS00 has been successfully added to your 
